{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:37:19Z","timestamp":1771486639088,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.gastha.2023.11.002","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T14:25:42Z","timestamp":1699971942000},"page":"162-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Perspectives on Outcome Prediction in Patients With Chronic Hepatitis B Virus Infection"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0664-9372","authenticated-orcid":false,"given":"Yun-Fan","family":"Liaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastha.2023.11.002_bib1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.gastha.2023.11.002_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.gastha.2023.11.002_bib3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gastha.2023.11.002_bib4","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2023.11.002_bib5","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.cgh.2020.04.091","article-title":"Should treatment indications for chronic hepatitis B be expanded?","volume":"10","author":"Jeng","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2023.11.002_bib6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41575-019-0197-8","article-title":"Clinical utility of HBV surface antigen quantification in HBV e antigen-negative chronic HBV infection","volume":"16","author":"Liaw","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2023.11.002_bib7","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jhep.2014.08.033","article-title":"Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course and management","volume":"61","author":"Chang","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gastha.2023.11.002_bib8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cgh.2010.02.023","article-title":"Hepatitis B virus DNA level predicts hepatic decompensation in patients with acute exacerbation of chronic hepatitis B","volume":"8","author":"Jeng","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2023.11.002_bib9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/hep.31525","article-title":"Hepatitis B flare after cessation of nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B: to retreat or not to retreat","volume":"73","author":"Liaw","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2023.11.002_bib10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s00535-022-01918-z","article-title":"Perspectives on current controversial issues in the management of chronic HBV infection","volume":"57","author":"Liaw","year":"2022","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.gastha.2023.11.002_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jcv.2013.08.010","article-title":"Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA","volume":"58","author":"Martinot-Peignoux","year":"2013","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.gastha.2023.11.002_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/hep.28552","article-title":"Serum levels of hepatitis B surface antigen and DNA can predict inactive carriers with low risk of disease progressio","volume":"64","author":"Liu","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2023.11.002_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1053\/j.gastro.2023.01.005","article-title":"Low hepatitis B core-related antigen levels correlate higher spontaneous seroclearance of hepatitis B surface antigen in chronic hepatitis B patients with high hepatitis B surface antigen levels","volume":"164","author":"Tseng","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2023.11.002_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cgh.2011.08.029","article-title":"Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection","volume":"10","author":"Chen","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2023.11.002_bib15","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/jvh.13114","article-title":"Off-therapy precipitous HBsAg decline predicts HBsAg loss after finite entecavir therapy in HBeAg-negative patients","volume":"26","author":"Jeng","year":"2019","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.gastha.2023.11.002_bib16","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/hep.25718","article-title":"A\u00a0large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance","volume":"56","author":"Seto","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2023.11.002_bib17","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1053\/j.gastro.2011.06.036","article-title":"Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma","volume":"141","author":"Chen","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2023.11.002_bib18","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/hep.22878","article-title":"Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time","volume":"49","author":"Tai","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2023.11.002_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161818","article-title":"Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment","volume":"132","author":"Grudda","year":"2022","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.gastha.2023.11.002_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.gastro.2010.04.052","article-title":"Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers","volume":"139","author":"Brunetto","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2023.11.002_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jac\/dkab360","article-title":"Highly significant differences in HBsAg kinetics among patients with two types of hepatitis B flare with and without retreatment","volume":"77","author":"Jeng","year":"2022","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.gastha.2023.11.002_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.gastha.2023.11.002_bib23","doi-asserted-by":"crossref","first-page":"748","DOI":"10.14309\/ajg.0000000000001691","article-title":"Hepatitis B core-related antigen stratifies the risk of liver cancer in HBeAg-negative patients with indeterminate phase","volume":"117","author":"Tseng","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2023.11.002_bib24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/gutjnl-2017-314904","article-title":"High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B","volume":"67","author":"Kim","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.gastha.2023.11.002_bib25","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1097\/HEP.0000000000000459","article-title":"Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase","volume":"78","author":"Huang","year":"2023","journal-title":"Hepatology"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572323001772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572323001772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:59:08Z","timestamp":1762646348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572323001772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2772572323001772"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2023.11.002","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perspectives on Outcome Prediction in Patients With Chronic Hepatitis B Virus Infection","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2023.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}